Fresenius | FRE - Ebitda


Fresenius reported EUR988M in EBITDA for its fiscal quarter ending in June of 2026.





Ebitda Change Date
Akzo Nobel EUR 398M 53M Jun/2026
Alcon AG USD 795M 478M Mar/2026
AstraZeneca USD 5.16B 510M Jun/2026
BASF EUR 2.45B 93M Jun/2026
Bayer EUR 2.14B 2.31B Jun/2026
Beiersdorf EUR 984M 147M Jun/2025
DaVita Healthcare Partners USD 746.81M 86.98M Jun/2026
Demant DKK 2.76B 165M Dec/2025
E.ON EUR 5.12B 2.28B Mar/2026
Essilor EUR 4.34B 1.25B Jun/2026
Fresenius EUR 988M 37M Jun/2026
Fresenius Medical Care EUR 824M 250M Mar/2026
Getinge SEK 1.89B 1.58B Jun/2026
Givaudan CHF 778M 195M Dec/2025
GlaxoSmithKline GBP 3.51B 734M Jun/2026
GN Store Nord DKK 491M 136M Mar/2026
GRIFOLS EUR 473M 120M Jun/2026
Hikma Pharmaceutical USD 369M 84M Dec/2024
Lonza CHF 1.01B 54M Dec/2025
Merck EUR 1.53B 87M Mar/2026
Novartis USD 6.48B 1.19B Jun/2026
Philips EUR 910M 343M Jun/2026
Roche Holding CHF 13.43B 744M Jun/2026
RWE EUR 1.63B 20M Mar/2026
Sanofi EUR 3.69B 375M Jun/2026
Smith & Nephew USD 796M 139M Dec/2025